Closed · RFA--FD-13-035 · CFDA 93.103 · Discretionary
Predictive Methods for Characterizing Product Performance in Pediatric Patients, Case Study: Furosemide
Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.
- up to $100K
- Award range
- Closed
- Status
- August 15, 2013
- Close date
- 3
- Expected awards
The verdict
Predictive Methods for Characterizing Product Performance in Pediatric Patients, Case Study: Furosemide is a closed discretionary listing from Food and Drug Administration that offered Up to $100,000 across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.
- up to $100K
- award range
- Closed
- application status
- 3
- expected awards
- 93.103
- CFDA program
Archived opportunity record
Predictive Methods for Characterizing Product… is closed (last close August 15, 2013). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 15, 2013
Est. Total Funding
$250,000
Expected Awards
3
Instrument
Grant
Description
This project follows after earlier CDER research projects in which in vitro furosemide dissolution and/or solubility data were collected in various dissolution media such as simulated gastric and intestinal fluids. In two different studies with different approaches and dissolution testing apparatus, furosemide dissolution was higher in medium containing milk and baby formula than that in standard buffer medium. This research project will allow collecting in vivo data when furosemide (the model drug) will be given with milk, baby formula and Ensure Plus™ to healthy adults. The suitability of the in vitro methods using dissolution media containing milk, baby formula and Ensure Plus for predicting in vivo performance of furosemide (a poorly soluble and poorly permeable drug), classified as BCS (Biopharmaceutic Classification System) Class IV drug will be determined.
Campus applicant desk · Consumer Protection
Grants.gov prints only higher-education applicant doors for Predictive Methods for Characterizing Product… (Public / state-controlled institutions of higher education). This reads as a campus competition desk, not a civic or commercial open call. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity codes span Consumer Protection · Food and Nutrition (CP;FN). Only 2 other Food and Drug Administration listings share this exact eligibility-code string (0% of 482).
- Code 06
- Public / state-controlled institutions of higher education
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Food and Drug Administration Research
U.S. Department of Health and Human Services
Agency Contact
Oluyemisi (Yemisi) Akinneye Grants Management Specialist Phone 3018270079
More from Food and Drug Administration
Federal and University Partnership to Improve the Safety of Seafood from the Gulf of America
Research, Education, and Outreach on Botanical Natural Products
Cooperative Agreement to Support Shellfish Safety Assistance Project
Education and Outreach to Tribal Producers through the Tribal Food Safety Alliance
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
What to do next
Predictive Methods for Characterizing Product… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
- Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
- Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |